How Third-Party Peptide Testing Labs Verify Purity: HPLC, Mass Spec, and Amino Acid Analysis

What does a third-party peptide testing lab actually do?

A third-party peptide testing lab receives a sealed vial from a researcher or vendor, runs a defined set of analytical methods on it, and issues a report that states what the material is and how much of it is present. The three core measurements are reverse-phase HPLC for chromatographic purity, liquid chromatography mass spectrometry (LC-MS) for identity, and amino acid analysis or a comparable quantitation for net peptide content. Labs may add endotoxin, water content, residual trifluoroacetic acid (TFA), and sterility checks depending on the request.

The distinguishing feature is independence. A vendor Certificate of Analysis (COA) is generated by or for the supplier, sometimes by the synthesis facility overseas, sometimes by a contracted lab. A third-party report is commissioned by someone with no stake in the result, on a sample pulled from the same batch a researcher would receive. That does not make the vendor COA worthless, but it changes what the number means. The existing guide on reading a peptide COA covers the document itself. This post covers the lab work behind it.

How does HPLC measure peptide purity?

Reverse-phase HPLC separates the components of a sample by hydrophobicity and reports purity as the target peak's share of the total integrated peak area. The lyophilized peptide is dissolved in a solvent, injected onto a C18 column, and pushed through with a gradient of increasing acetonitrile in water, both typically containing 0.1% TFA as an ion-pairing agent. Components elute in order of their affinity for the stationary phase, and a UV detector records absorbance against time.

Two detection wavelengths matter. At 214 nm to 220 nm the peptide bond itself absorbs, so every peptide species in the sample registers regardless of sequence. At 280 nm only aromatic residues (tryptophan, tyrosine, to a lesser degree phenylalanine) absorb, so a 280 nm trace under-reports impurities that lack those residues. A report that states purity at 214 nm or 220 nm is the more conservative figure. A report that states only 280 nm, or no wavelength at all, is leaving out the information needed to interpret the number.

Purity by HPLC is a ratio of what the method separates and the detector sees. Deletion sequences, diastereomers from epimerization, and oxidized variants can elute close enough to the main peak to be integrated with it. The peptide purity guide discusses why two batches with identical 99% figures can differ in composition. The practical takeaway is that a good third-party report lists the column, gradient, flow rate, wavelength, and run time, because purity is a statement about the method as much as the sample.

How does mass spectrometry confirm identity?

HPLC tells a lab how clean a sample is. It does not tell the lab what the sample is. A 99% pure peak could be the wrong peptide. Mass spectrometry closes that gap by measuring the mass-to-charge ratio of the ionized peptide and comparing the observed molecular weight against the theoretical value calculated from the sequence.

Electrospray ionization (ESI) is the usual method for peptides. It produces multiply charged ions, so a peptide with a molecular weight of roughly 4,700 Da may appear as a series of peaks at m/z values corresponding to +3, +4, +5, and higher charge states. Deconvolution software collapses these into a single neutral mass. A match within the instrument's tolerance, typically under 1 Da for a well-calibrated instrument at this size range, confirms that the main peak has the expected mass. It does not, on its own, confirm sequence order, since two peptides with the same amino acid composition in different orders have the same mass. Tandem MS (MS/MS) fragmentation or Edman sequencing addresses that when required.

Mass spectrometry also catches impurity classes that HPLC integrates into the main peak. A deletion sequence missing a single residue shows up as a distinct mass. Oxidation adds 16 Da. Deamidation adds roughly 1 Da, which is harder to resolve but visible on high-resolution instruments. A third-party report that pairs the HPLC chromatogram with an ESI-MS spectrum, and states the theoretical versus observed mass, is providing the two halves of the purity question: how much, and of what.

What is amino acid analysis and why does net peptide content differ from purity?

Amino acid analysis (AAA) hydrolyzes the peptide into its constituent amino acids, derivatizes them, and quantifies each against calibrated standards. The output is the absolute amount of peptide in the vial, expressed as net peptide content. This is a different quantity from HPLC purity, and conflating the two is one of the most common misreadings of a testing report.

HPLC purity is relative: of the peptide-like material present, what fraction is the target. Net peptide content is absolute: of the total mass in the vial, what fraction is peptide at all. A lyophilized peptide contains bound water, counter-ions (usually TFA or acetate from purification), and sometimes residual salts. These are not impurities in the HPLC sense because they do not absorb at 214 nm, but they are mass on the scale. A vial labeled at a given weight with 99% HPLC purity might contain 75% to 90% peptide by mass, with the remainder being water and counter-ion. Research applications that depend on molar concentration need net peptide content, not purity, and a third-party lab is the usual source for that measurement.

Queries for "accredited amino acid analysis laboratory" are common because AAA requires specialized instrumentation (ion-exchange or pre-column derivatization with UV or fluorescence detection) and calibrated standards that not every HPLC-equipped facility maintains. A lab offering AAA typically states the hydrolysis conditions and the reference standards used.

What does ISO 17025 accreditation cover?

ISO/IEC 17025 is the international standard for the competence of testing and calibration laboratories. Accreditation means an external body has audited the lab's quality management system, staff competence, equipment calibration, method validation, and record-keeping against the standard and found them conforming. Accreditation bodies maintain public registers; in the United States these include A2LA and ANAB, and in the United Kingdom UKAS.

Two limits matter. First, accreditation is granted for a defined scope. A lab accredited for pharmaceutical HPLC assays may not be accredited for peptide mass spectrometry. The scope document lists which methods are covered, and a claim of "ISO 17025 accredited" without a scope is incomplete. Second, accreditation attests to the process, not the specific result. An accredited lab can still produce a purity figure that a different method would report differently, because the method itself defines what is measured. What accreditation does provide is traceability: the calibration records, the analyst training, and the raw data exist and were audited.

Third-party peptide testing labs that publish their scope, their methods, and example reports are giving researchers what they need to interpret a number. Labs that publish only a headline purity figure are not.

How does a third-party report differ from a vendor COA?

A vendor COA and a third-party report can contain the same tests, but they differ in provenance, sample selection, and incentives. A vendor COA usually reflects the synthesis facility's release testing on the bulk lot before it was aliquoted and shipped. It says what the material was at the point of manufacture. A third-party report reflects a sample from the finished product, after transit and storage, and states what it is at the point of receipt.

Reading the two together is more informative than either alone. Matching lot numbers, a matching theoretical mass, and HPLC purity within a point or two of each other suggest the vendor's documentation is describing the product actually shipped. A large gap in purity, a mass mismatch, or a vendor COA with no method details and no chromatogram are the signals that warrant a third-party test before the material is used in work where the result depends on it.

Vendors that publish batch-level third-party results, rather than a single representative COA reused across lots, are removing the sampling question entirely. The quality documentation comparison covers what to expect at each documentation tier.

What should a researcher look for in a third-party testing report?

A usable third-party peptide testing report has, at minimum: the sample identifier and lot number as received; the date of analysis; the HPLC method (column, gradient, wavelength, flow rate) with the chromatogram attached; the observed versus theoretical mass from MS with the spectrum attached; net peptide content or a statement that it was not measured; and the analyst or lab signature with a report ID that can be confirmed with the lab. Endotoxin (LAL assay, reported in EU/mg) and water content (Karl Fischer) are useful additions for material intended for cell-based work.

Absent any of these, the number on the page is a claim rather than a measurement. Amino Foundry publishes HPLC purity and MS identity documentation per batch, and researchers are encouraged to commission independent testing on any lot where the application requires it.

All compounds referenced in this article are supplied for research purposes only and are not for human use. Nothing here describes or endorses any use of these materials outside laboratory research. These products are not intended to diagnose, treat, cure, or prevent any disease.